Evidence map›Paper›PMID 39924910›Full record

ArticleJournal of the American Chemical Society2025

Red-Light-Active

Alexios Stamoulis, Mauro Mato, Paolo Cleto Bruzzese, Markus Leutzsch, Alejandro Cadranel, Marcos Gil-Sepulcre, Frank Neese, Josep Cornella

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Unveiling the Potential ofJournal of the American Chemical Society · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alexios StamoulisMax-Planck-Institut für Kohlenforschung, Kaiser-Wilhelm-Platz 1, Mülheim an der Ruhr 45470, Germany.ORCID 0000-0003-4886-0512
Mauro MatoMax-Planck-Institut für Kohlenforschung, Kaiser-Wilhelm-Platz 1, Mülheim an der Ruhr 45470, Germany.ORCID 0000-0002-2931-5060
Paolo Cleto BruzzeseMax-Planck-Institut für Chemische Energiekonversion, Stiftstrasse 34-36, Mülheim an der Ruhr 45470, Germany.ORCID 0000-0002-2070-836X
Markus LeutzschMax-Planck-Institut für Kohlenforschung, Kaiser-Wilhelm-Platz 1, Mülheim an der Ruhr 45470, Germany.ORCID 0000-0001-8171-9399
Alejandro CadranelUniversidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales, Departamento de Química Inorgánica, Analítica y Química Física, Pabellón 2, Ciudad Universitaria, C1428EHA Buenos Aires, Argentina.ORCID 0000-0002-6597-4397
Marcos Gil-SepulcreMax-Planck-Institut für Chemische Energiekonversion, Stiftstrasse 34-36, Mülheim an der Ruhr 45470, Germany.
Frank NeeseMax-Planck-Institut für Kohlenforschung, Kaiser-Wilhelm-Platz 1, Mülheim an der Ruhr 45470, Germany.ORCID 0000-0003-4691-0547
Josep CornellaMax-Planck-Institut für Kohlenforschung, Kaiser-Wilhelm-Platz 1, Mülheim an der Ruhr 45470, Germany.ORCID 0000-0003-4152-7098

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the progress made in the field of synthetic organic photocatalysis over the past decade, the use of higher wavelengths, especially those in the deep-red portion of the electromagnetic spectrum, remains comparatively rare. We have previously disclosed that a well-defined

Identifiers

PMID39924910
PMCPMC11848931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.